![Hany Massarany](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hany Massarany
Vorsitzender bei
ACCELERATE DIAGNOSTICS, INC.
Vermögen: 409 824 $ am 30.06.2026
Profil
Hany Massarany currently works at Accelerate Diagnostics, Inc., as Chairman from 2023, Biodesix, Inc., as Independent Director from 2020, and Planet Innovation Pty Ltd., as Non-Executive Director.
Mr. Massarany also formerly worked at GenMark Diagnostics, Inc., as President & Chief Executive Officer in 2020, Roche Holding AG, as Head-Roche Tissue Diagnostics from 2009 to 2011, and Ventana Medical Systems, Inc., as President from 2009 to 2011.
Mr. Massarany received his Masters Business Admin degree from the University of Melbourne and undergraduate degree from Monash University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIODESIX, INC. 0,23 % | 04.03.2026 | 18.174 ( 0,23 % ) | 409 824 $ | 30.06.2026 |
Aktive Positionen von Hany Massarany
| Unternehmen | Position | Beginn |
|---|---|---|
| BIODESIX, INC. | Direktor/Vorstandsmitglied | 20.07.2020 |
| ACCELERATE DIAGNOSTICS, INC. | Vorsitzender | 22.02.2023 |
Planet Innovation Pty Ltd.
 Planet Innovation Pty Ltd. Medical SpecialtiesHealth Technology Manufactures and supplies medical equipment | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Hany Massarany
| Unternehmen | Position | Ende |
|---|---|---|
| GENMARK DIAGNOSTICS, INC. | Vorstandsvorsitzender | 01.03.2020 |
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and sells proprietary instruments and reagent systems | Präsident | 01.04.2011 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01.04.2011 |
Ausbildung von Hany Massarany
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Accelerate Diagnostics, Inc.
 Accelerate Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostics solutions | Health Technology |
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and sells proprietary instruments and reagent systems | Electronic Technology |
Biodesix, Inc.
 Biodesix, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic research and clinical trial testing services & engages in discovery, development and commercialization of therapeutics | Health Services |
GenMark Diagnostics, Inc.
 GenMark Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes immunoassays, serology, molecular & tissue diagnostic testing systems | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Planet Innovation Pty Ltd.
Planet Innovation Pty Ltd. Medical SpecialtiesHealth Technology Manufactures and supplies medical equipment | Health Technology |
